Publications
- Thompson, C. P., Lourenço, J., Walters, A. A., Obolski, U., Edmans, M., Palmer, D. S., Kooblall, K., Carnell, G. W., O'Connor, D., Bowden, T. A., Pybus, O. G., Pollard, A. J., Temperton, N. J., Lambe, T., Gilbert, S. C., & Gupta, S. (2018). A naturally protective epitope of limited variability as an influenza vaccine target. Nature communications, 9(1), 3859.
https://doi.org/10.1038/s41467-018-06228-8
- Rosch, J. W., Iverson, A. R., Humann, J., Mann, B., Gao, G., Vogel, P., Mina, M., Murrah, K. A., Perez, A. C., Edward Swords, W., Tuomanen, E. I., & McCullers, J. A. (2014). A live-attenuated pneumococcal vaccine elicits CD4+ T-cell dependent class switching and provides serotype independent protection against acute otitis media. EMBO molecular medicine, 6(1), 141–154.
https://doi.org/10.1002/emmm.201202150
- Ramesh, A., Mao, J., Lei, S., Twitchell, E., Shiraz, A., Jiang, X., Tan, M., & Yuan, A. L. (2019). Parenterally Administered P24-VP8* Nanoparticle Vaccine Conferred Strong Protection against Rotavirus Diarrhea and Virus Shedding in Gnotobiotic Pigs. Vaccines, 7(4), 177.
https://doi.org/10.3390/vaccines7040177